Navigation Links
New Study Shows Viability of Heart Pumps for Older Heart-Failure Patients
Date:6/28/2011

SAN DIEGO, June 28, 2011 /PRNewswire/ -- Results of a clinical research study at Sharp Memorial Hospital indicate that patients 70 years of age or older have good functional recovery, survival and quality of life at two years when undergoing left ventricular assist device (LVAD) therapy for heart failure.  The study was released in the June 21 edition of the Journal of the American College of Cardiology.

(Photo: http://photos.prnewswire.com/prnh/20110628/LA27443)

The study's lead author, Robert M. Adamson, MD, medical director of the cardiac transplantation program at Sharp Memorial, and colleagues concluded that LVAD therapy should be considered an "attractive option" for some patients, and that advanced age alone should not determine whether or not a patient receives LVAD support.  The research team also noted that "very good results can be achieved in a community hospital setting with a focused effort from a dedicated team."

Patients in the study were implanted with Thoratec's HeartMate II LVAD, which received FDA approval for bridge to transplantation therapy in April 2008 and for destination therapy in January 2010 for transplant-ineligible heart-failure patients.  At Sharp Memorial, which serves as a Thoratec training site, the transplant team has implanted nearly 130 HeartMate II devices.  The physicians and staff there have been working together since the 1980s and performed San Diego's first heart transplant in 1985.  Since then, the team has performed more than 340 heart transplants and numerous implant procedures.  They also have the longest LVAD-supported patient in the world, who first received the device more than nine years ago in March 2002.  

"With an increasing population of elderly patients with advanced heart failure who have limited treatment options, the FDA's approval of LVAD therapy make sense f
'/>"/>

SOURCE Sharp HealthCare
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
5. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
6. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
7. Study Suggests High-Dose Fish Oil May Significantly Improve Behavior in Children with ADHD
8. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
9. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
10. MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus
11. Sarasotas Roskamp Institute Releases Study Defining a Mechanism for Development of Obesity and the Metabolic Syndrome, Forerunners of Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... 27, 2015  Pharmacyclics, Inc. (NASDAQ: ... study published in the Proceedings of the ... that showed when ibrutinib (IMBRUVICA ® ) was ... suppression of tumor growth was enhanced suggesting a ... hematologic cancers and solid tumors with the combination. ...
(Date:2/27/2015)... YORK , Feb. 27, 2015 Securities ... the board of Salix Pharmaceuticals, Ltd. (NASDAQ: ... $158.00 per share. Concerned SLXP investors are encouraged to ... The investigation focuses upon the shareholder ... agreement, Salix shareholders would receive only $158.00 per share ...
(Date:2/27/2015)... 27, 2015  Boston Scientific Corporation (NYSE: ... 2015 Annual Healthcare Conference on March 10 in ... Brennan , executive vice president and chief financial officer, ... will participate in a 25-minute question and answer session ... 1:05 p.m. ET. Following a 5-minute break, a question ...
Breaking Medicine Technology:In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 2In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 3In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 4In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 5In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 6In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 7In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 8In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 9Boston Scientific to Participate in the Barclays 2015 Annual Healthcare Conference 2
(Date:3/1/2015)... 2015 Comparing a new source of ... the Quotes Pros portal this year. A broad range ... rates that are being supplied through the finder at ... and prices available for each policy is now provided ... system user will first be asked to present their ...
(Date:3/1/2015)... Ticket Down is a reputable source for authentic ... Deadheads have been anxiously anticipating this blockbuster weekend ever ... formed 50 years ago back in the 60s in Palo ... untimely death of Jerry Garcia in 1995. This beloved ... rock, bluegrass, folk, space rock and country to become an ...
(Date:3/1/2015)... 2015 “ The Barrel Mill ” was ... which takes a look at the latest and coolest technology ... of NewsWatch and a technology expert, conducted the review and ... to drinks. , According to Home Distillation of Alcohol, it's ... Well, there’s a pretty cool product that’ll help anyone achieve ...
(Date:2/28/2015)... In recent years Medical Marijuana has continuously ... as a way for them to expand their patient base ... medicine. Since the FDA still lists Cannabis as a Schedule ... licensed physicians that can help guide them when recommending ... in Santa Cruz, CA is a leader in the ...
(Date:2/28/2015)... With their commitment to achieving physical results ... exercise to their already robust library of oblique exercises. ... known as, is often performed on a stationary piece ... a relatively safe manner and can be performed by ... description of “Rope Pulls” is located in the oblique ...
Breaking Medicine News(10 mins):Health News:United Auto Insurance Rates Now Quoted at Consumer Insurance Portal Online 2Health News:Grateful Dead Tickets at Soldier Field in Chicago: Ticket Down Slashes Grateful Dead Ticket Prices in Chicago at Soldier Field for 4th of July Weekend Celebration 2Health News:An Oak Infusion Spiral was Featured on NewsWatch Television on January 30, 2015 2Health News:Reputable Cannabis Doctor In Santa Cruz and Monterey Joins the Medical Cannabis Network 2
... , ... ... ... ...
... ... ... ... ...
... ... ... ... ...
... , ... ... ... ...
... ... of the First EcoAdvisor to Achieve EcoDirector Level With Their Business. , ... Midland (PRWEB) February 24, 2010 ... the highest level of achievement, EcoDirector status. Michelle and Kris Harvey reached this level ...
... , ... ... ... ...
Cached Medicine News:Health News:Jamba Juice Unveils All Fruit Smoothie School Lunch Program 2Health News:Jamba Juice Unveils All Fruit Smoothie School Lunch Program 3Health News:Jamba Juice Unveils All Fruit Smoothie School Lunch Program 4Health News:Jamba Juice Unveils All Fruit Smoothie School Lunch Program 5Health News:Wounded Soldier Who Received Historic Cell Transplant Gets Standing Ovation at Diabetes Research Institute Benefit 2Health News:Wounded Soldier Who Received Historic Cell Transplant Gets Standing Ovation at Diabetes Research Institute Benefit 3Health News:Wounded Soldier Who Received Historic Cell Transplant Gets Standing Ovation at Diabetes Research Institute Benefit 4Health News:Wounded Soldier Who Received Historic Cell Transplant Gets Standing Ovation at Diabetes Research Institute Benefit 5Health News:Wounded Soldier Who Received Historic Cell Transplant Gets Standing Ovation at Diabetes Research Institute Benefit 6Health News:Stevens Hospital One Step Closer to Affiliation with Swedish 2Health News:Stevens Hospital One Step Closer to Affiliation with Swedish 3Health News:Stevens Hospital One Step Closer to Affiliation with Swedish 4Health News:Stevens Hospital One Step Closer to Affiliation with Swedish 5Health News:Stevens Hospital One Step Closer to Affiliation with Swedish 6Health News:Stevens Hospital One Step Closer to Affiliation with Swedish 7Health News:Stevens Hospital One Step Closer to Affiliation with Swedish 8Health News:Stroke Conference Daily News Summary 2Health News:Stroke Conference Daily News Summary 3Health News:Stroke Conference Daily News Summary 4Health News:Stroke Conference Daily News Summary 5Health News:Stroke Conference Daily News Summary 6Health News:OnlyGreen Celebrates First EcoDirector 2Health News:ANF Group's Tour de Broward Raises Money for Joe DiMaggio Children's Hospital 2Health News:ANF Group's Tour de Broward Raises Money for Joe DiMaggio Children's Hospital 3Health News:ANF Group's Tour de Broward Raises Money for Joe DiMaggio Children's Hospital 4
Each handle is designed to fit a specific trephine size....
Reusable, stainless steel trephine with handle....
Reusable, stainless steel trephine with handle....
Each handle is designed to fit a specific trephine size. For use in performing free-hand uniform donor buttons....
Medicine Products: